GTS Securities LLC Has $584,000 Stock Position in UnitedHealth Group Incorporated $UNH

GTS Securities LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 72.6% during the 2nd quarter, Holdings Channel.com reports. The firm owned 1,405 shares of the healthcare conglomerate’s stock after selling 3,727 shares during the quarter. GTS Securities LLC’s holdings in UnitedHealth Group were worth $584,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the business. Norges Bank bought a new position in shares of UnitedHealth Group during the 4th quarter worth about $4,376,167,000. Corient Private Wealth LP acquired a new position in UnitedHealth Group in the second quarter worth about $245,516,000. Legal & General Group Plc acquired a new stake in UnitedHealth Group during the second quarter valued at approximately $2,444,928,000. Jupiter Topco LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $2,019,844,000. Finally, BlackRock Inc. lifted its position in shares of UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after buying an additional 3,395,530 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have issued reports on UNH shares. Mizuho increased their price objective on UnitedHealth Group from $470.00 to $493.00 and gave the stock an “outperform” rating in a research note on Monday, July 20th. HC Wainwright set a $492.00 target price on shares of UnitedHealth Group in a report on Wednesday, May 27th. Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Weiss Ratings lowered shares of UnitedHealth Group from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, July 28th. Finally, DA Davidson set a $512.00 target price on UnitedHealth Group in a report on Tuesday, July 21st. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $456.56.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.19% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $393.99 on Monday. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $353.64 billion, a price-to-earnings ratio of 25.35, a PEG ratio of 1.36 and a beta of 0.62. The firm’s 50 day moving average is $413.28 and its 200-day moving average is $360.71. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 19.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be issued a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s payout ratio is currently 59.72%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.